biostudies-literatureDeloria Knoll MBill and Melinda Gates Foundation742https://www.ebi.ac.uk/biostudies/studies/S-EPMC8066045biostudies-literatureUnknown9(4)Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 MicroorganismsGlobal Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.PMC8066045INV-010429 / OPP1189065Leon MEMungun TDe Wals PHetrich MKPeterson MESavulescu CDagan RCamilli RCiruela PSinkovec Zorko NBigogo GOishi KSaha SKMad'arova LChan GGeorgakopoulou TParagi MSetchanova LPMackenzie GADanis KKristinsson KGChanto Chacon Gvan der Linden MYildirim IKagucia EWYang YCook HScott JANuorti JPBennett JCLepp THo PLSavrasova LKozakova JGalloway YNzoyikorera NFeikin DRKellner JDLadhani SNHilty MMwenda JMDesmet SCastilla JHammitt LLJayasinghe SRafai EVestrheim DFvon Gottberg ACohen ALKleynhans JSkoczynska AGarcia Quesada MAukes LLara CSAmpofo KHayford KDeloria Knoll MMcGeer Ade Miguel SCorcoran MKnol MJSinkevitch JNPilishvili TScott KJPuentes RBruce MGDe Oliveira LHValentiner-Branth PThe Pserenade TeamBrandileone MCSerhan FBacci SSwarthout TDfalseGlobal Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 2021-01-01T00:00:00Z2021 Apr2025-04-07T05:15:12.513Z2025-04-07T05:15:12.513ZS-EPMC80660453391812710.3390/microorganisms9040742